CINECA IRIS Institutional Research Information System

BASOLO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.068
AS - Asia 16.926
EU - Europa 14.354
SA - Sud America 2.679
Continente sconosciuto - Info sul continente non disponibili 929
AF - Africa 820
OC - Oceania 26
Totale 70.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.098
SG - Singapore 5.268
CN - Cina 4.559
IT - Italia 4.320
HK - Hong Kong 2.919
SE - Svezia 2.496
BR - Brasile 2.236
DE - Germania 2.219
VN - Vietnam 1.421
BG - Bulgaria 1.106
GB - Regno Unito 946
TR - Turchia 842
CA - Canada 707
FR - Francia 615
FI - Finlandia 574
RU - Federazione Russa 535
AT - Austria 449
UA - Ucraina 396
IN - India 377
CI - Costa d'Avorio 323
KR - Corea 316
JP - Giappone 295
BD - Bangladesh 177
SN - Senegal 151
NL - Olanda 148
AR - Argentina 140
CH - Svizzera 140
IQ - Iraq 132
MX - Messico 91
PK - Pakistan 90
BE - Belgio 89
ID - Indonesia 77
SA - Arabia Saudita 77
ZA - Sudafrica 69
VE - Venezuela 66
PL - Polonia 65
EC - Ecuador 64
MA - Marocco 64
CO - Colombia 55
UZ - Uzbekistan 55
ES - Italia 52
NG - Nigeria 47
JO - Giordania 40
JM - Giamaica 37
KE - Kenya 29
EG - Egitto 28
PY - Paraguay 28
MY - Malesia 27
LT - Lituania 26
CL - Cile 25
IL - Israele 25
UY - Uruguay 25
AU - Australia 23
IR - Iran 23
TN - Tunisia 23
PA - Panama 21
PE - Perù 21
AZ - Azerbaigian 20
IE - Irlanda 20
NP - Nepal 20
PH - Filippine 20
RO - Romania 19
CR - Costa Rica 18
CZ - Repubblica Ceca 17
DZ - Algeria 17
TT - Trinidad e Tobago 17
AL - Albania 16
BJ - Benin 16
GR - Grecia 16
DO - Repubblica Dominicana 15
HU - Ungheria 15
OM - Oman 15
BO - Bolivia 14
ET - Etiopia 14
EU - Europa 14
AE - Emirati Arabi Uniti 13
PT - Portogallo 13
HN - Honduras 12
KZ - Kazakistan 12
LB - Libano 12
PS - Palestinian Territory 12
RS - Serbia 12
TW - Taiwan 11
NI - Nicaragua 10
BY - Bielorussia 8
EE - Estonia 8
KG - Kirghizistan 8
BH - Bahrain 7
BN - Brunei Darussalam 7
GA - Gabon 6
GT - Guatemala 6
SV - El Salvador 6
AM - Armenia 5
AO - Angola 5
BB - Barbados 5
BZ - Belize 5
DK - Danimarca 5
LK - Sri Lanka 5
QA - Qatar 5
SY - Repubblica araba siriana 5
Totale 69.773
Salva come PNG Salva come JPEG
Città #
Ashburn 3.849
Fairfield 3.026
Singapore 2.885
Hong Kong 2.777
Woodbridge 2.476
Dallas 2.208
Chandler 2.170
Houston 1.818
San Jose 1.741
Santa Clara 1.655
Ann Arbor 1.627
Seattle 1.281
Wilmington 1.118
Sofia 1.097
Cambridge 1.009
Shanghai 1.002
Beijing 991
New York 815
Milan 718
Boardman 530
Ottawa 524
Izmir 511
Serra 504
Princeton 485
Los Angeles 456
Lawrence 442
Jacksonville 439
Lauterbourg 398
Medford 393
Vienna 392
Council Bluffs 384
Hefei 375
Ho Chi Minh City 356
Abidjan 322
Nanjing 318
Seoul 298
Des Moines 258
Florence 257
Tokyo 256
Hanoi 245
Pisa 244
Munich 227
London 222
Istanbul 210
Frankfurt am Main 202
San Diego 200
Buffalo 191
São Paulo 191
Columbus 189
Dearborn 189
The Dalles 176
Rome 164
Redondo Beach 162
Dakar 151
Dong Ket 147
Helsinki 127
Nanchang 120
Bern 115
Bremen 112
Boulder 93
Chicago 92
Falls Church 91
Ogden 91
Kunming 90
Orem 84
Brussels 81
Turku 79
Rio de Janeiro 74
Lancaster 70
Naples 70
Shenyang 69
Jüchen 68
Changsha 67
Redwood City 63
Belo Horizonte 57
Hebei 54
Washington 54
Pune 53
Baghdad 52
Düsseldorf 51
Tashkent 51
Toronto 51
Bologna 49
Da Nang 48
Phoenix 48
Fuzhou 47
Guangzhou 47
San Francisco 47
Norwalk 46
Nürnberg 46
Tianjin 46
Cascina 43
Montreal 43
Warsaw 43
Brasília 42
Jiaxing 42
Amsterdam 41
Atlanta 41
Lagos 41
Nuremberg 41
Totale 48.151
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.171
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 341
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 277
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: A 10 years follow up study 269
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 268
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 261
ALL-TRANS RETINOIC ACID TREATMENT INHIBITS THE GROWTH OF RARb mRNA EXPRESSING THYROID CANCER CELL LINES BUT DOES NOT RE-INDUCE THE EXPRESSION OF THYROID SPECIFIC GENES 259
null 259
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 257
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 254
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 253
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 247
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 244
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 242
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 239
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 238
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 233
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 228
Molecular testing in the diagnosis of differentiated thyroid carcinomas 228
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 227
Ret Genetic Screening in Patients with Medullary Thyroid Cancer and Their Relatives: Experience with 807 Individuals at One Center 227
Developing a tool that could reliably refute total thyroidectomy for solitary Bethesda IV thyroid nodules 227
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 226
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 225
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 222
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 222
Picornavirus-induced immuno-suppression 220
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 218
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 218
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 218
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 217
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 216
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 216
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 213
A pandemic recap: lessons we have learned 211
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 209
Metastasis of renal cell carcinoma to the parathyroid gland 16 years after radical nephrectomy: A case report 209
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 207
A proteomic approach to study parathyroid glands 206
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 204
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 204
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 204
PRODUCTIVE HIV-1 INFECTION OF NORMAL HUMAN MAMMARY EPITHELIAL-CELLS 203
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 201
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 201
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 196
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Surgical treatment of pleural recurrence from thymoma 195
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes 192
Prevalence of papillary thyroid cancer (PTC) in patients affected by medullary thyroid cancer (MTC) 192
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 192
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 192
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 192
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 191
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 191
miR-19a and miR-20a and tissue factor expression in activated human peripheral blood mononuclear cells 191
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 191
KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) 190
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 190
FR-MLV INFECTION INDUCES ERYTHROLEUKEMIA INSTEAD OF LYMPHOID LEUKEMIA IN MICE GIVEN PITUITARY GRAFTS 189
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 189
MULTIPLE ORGAN-REACTIVITY OF MONOCLONAL AUTOANTIBODIES TO MOUSE ERYTHROCYTES 189
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 189
DIABETES MELLITUS 188
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer 188
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 188
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes 187
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 186
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 186
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 186
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 185
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 185
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 184
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 184
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 184
SYSTEMIC LYMPHOID ATROPHY IN COXSACKIE-VIRUS B3-INFECTED MICE - EFFECTS OF VIRUS AND IMMUNOPOTENTIATING AGENTS 183
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 183
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 183
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 182
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations 181
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 181
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 181
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 180
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 180
Influence of T and N stages on long term survival in resectable small cell lung cancer 179
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 179
MATRIGEL PROMOTES RETINOBLASTOMA CELL-GROWTH INVITRO AND INVIVO 178
Ectopic expression of bone sialoprotein in human thyroid cancer 178
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders 178
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 178
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 178
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients 177
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 177
GENETIC MARKERS TO DISCRIMINATE BENIGN AND MALIGNANT THYROID NODULES WITH UNDETERMINED CYTOLOGY IN AN AREA OF BORDERLINE IODINE DEFICIENCY. 177
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 177
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 177
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 177
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 177
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 176
Totale 21.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.230 0 221 151 396 993 829 161 236 281 264 292 1.406
2022/20237.074 888 955 513 640 754 885 99 572 1.192 64 433 79
2023/20244.448 476 416 481 357 634 834 189 155 145 116 174 471
2024/202514.989 123 570 152 900 1.445 1.488 1.210 851 1.579 1.875 1.578 3.218
2025/202615.991 1.077 2.198 2.206 1.391 1.470 1.416 2.427 703 804 1.445 566 288
2026/2027578 377 201 0 0 0 0 0 0 0 0 0 0
Totale 70.802